AI-generated summary
The authors used a class IV dual-wavelength near-infrared laser on two human breast cancer cell lines and on normal skin fibroblasts in a laboratory study. They report that, under the conditions tested, laser exposure did not significantly change cancer cell viability, proliferation, apoptosis, cell cycle or colony formation. The authors state that further studies are needed before the treatment can be considered safe for postmastectomy lymphedema.
- Who or what was studied
- Two human breast adenocarcinoma cell lines (MCF7 and MDA-MB361) and human dermal fibroblasts as normal control, in vitro
- Wavelengths
- 808, 905 nm
- Limits stated in the abstract
- The study is limited to the laser source, treatment conditions and in vitro models used, and the authors state that further studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 905 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Near-infrared, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.